BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 28382507)

  • 1. Cisplatin nephrotoxicity: a review of the literature.
    Manohar S; Leung N
    J Nephrol; 2018 Feb; 31(1):15-25. PubMed ID: 28382507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.
    Pabla N; Murphy RF; Liu K; Dong Z
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F505-11. PubMed ID: 19144690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
    Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.
    Freitas-Lima LC; Budu A; Arruda AC; Perilhão MS; Barrera-Chimal J; Araujo RC; Estrela GR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saving ears and kidneys from cisplatin.
    Wensing KU; Ciarimboli G
    Anticancer Res; 2013 Oct; 33(10):4183-8. PubMed ID: 24122981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy.
    Li C; Li L; Yi Y; Wang W; Yuan J; Tan F; Fang D; Zeng S; Zhou H; Jiang H
    Biochem Pharmacol; 2020 Jul; 177():114021. PubMed ID: 32389634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
    Ciarimboli G; Deuster D; Knief A; Sperling M; Holtkamp M; Edemir B; Pavenstädt H; Lanvers-Kaminsky C; am Zehnhoff-Dinnesen A; Schinkel AH; Koepsell H; Jürgens H; Schlatter E
    Am J Pathol; 2010 Mar; 176(3):1169-80. PubMed ID: 20110413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells.
    Gao H; Zhang S; Hu T; Qu X; Zhai J; Zhang Y; Tao L; Yin J; Song Y
    Chem Biol Interact; 2019 Jan; 297():130-140. PubMed ID: 30452898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
    Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
    Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platinum agent-induced nephrotoxicity via organic cation transport system].
    Yonezawa A
    Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury.
    Huang D; Wang C; Duan Y; Meng Q; Liu Z; Huo X; Sun H; Ma X; Liu K
    Toxicol Appl Pharmacol; 2017 Jul; 326():15-24. PubMed ID: 28414026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute nephrotoxicity of cisplatin: molecular mechanisms.
    Peres LA; da Cunha AD
    J Bras Nefrol; 2013; 35(4):332-40. PubMed ID: 24402113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cisplatin-induced injury in human kidney organoids.
    Digby JLM; Vanichapol T; Przepiorski A; Davidson AJ; Sander V
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F971-F978. PubMed ID: 32150447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury.
    Domitrović R; Cvijanović O; Šušnić V; Katalinić N
    Toxicology; 2014 Oct; 324():98-107. PubMed ID: 25043994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the protection of growth hormone in cisplatin-induced nephrotoxicity: The impact of IGF-1 on the Keap1-Nrf2/HO-1 signaling.
    Mahran YF
    Life Sci; 2020 Jul; 253():117581. PubMed ID: 32209424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnane X receptor (PXR) protects against cisplatin-induced acute kidney injury in mice.
    Luan Z; Wei Y; Huo X; Sun X; Zhang C; Ming W; Luo Z; Du C; Li Y; Xu H; Lu H; Zheng F; Guan Y; Zhang X
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):165996. PubMed ID: 33127475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
    Yonezawa A; Inui K
    Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysregulation and protection in cisplatin nephrotoxicity.
    Yang Y; Liu H; Liu F; Dong Z
    Arch Toxicol; 2014 Jun; 88(6):1249-56. PubMed ID: 24859930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.
    Solanki MH; Chatterjee PK; Gupta M; Xue X; Plagov A; Metz MH; Mintz R; Singhal PC; Metz CN
    Am J Physiol Renal Physiol; 2014 Aug; 307(4):F369-84. PubMed ID: 24944268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
    Tanase DM; Gosav EM; Radu S; Costea CF; Ciocoiu M; Carauleanu A; Lacatusu CM; Maranduca MA; Floria M; Rezus C
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.